McClatchy reports on this trend. Among American workers, employer-provided retiree coverage has dropped from 29 percent in 1997 to 17.7 percent in 2010.
The Chordoma Foundation has made a seed grant of $75,000 to Adrienne Flanagan, M.D., Ph.D., of University College, London, and her Jackson Laboratory collaborator, Mike Sasner, Ph.D., to develop a new mouse model for chordoma, a difficult-to-treat bone cancer affecting the skull and spine.
Auxogyn, Inc., a company dedicated to advancing women's reproductive health, today announced an exclusive license agreement with Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany which operates as EMD Serono in the United States and Canada, for Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test.
New data show ketamine (a drug widely used for anaesthesia and pain relief) has a rapid antidepressant effect in some patients with severe depression. The first UK study of ketamine intravenous infusions in people with treatment-resistant depression was conducted by the Oxford Health NHS Foundation Trust and the University of Oxford.
Clinical Therapeutics features a special report in its March issue focusing on the science and policy leading up to the US Food and Drug Administration's (FDA) preliminary steps toward restricting industrially produced trans fatty acids, or trans fat, at the federal level.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.
The most progressive minds in Europe's pharmaceutical research community will convene at the PRO & eCOA Congress, Europe 3-5 June in Barcelona, Spain.
In a first-of-its-kind study, a team of environmental engineers from the Cockrell School of Engineering at The University of Texas at Austin found that infants are exposed to high levels of chemical emissions from crib mattresses while they sleep.
QIAGEN N.V. today announced two important new product launches which address workflow challenges in next-generation sequencing (NGS) applications.
Janssen R&D Ireland (Janssen) announced today that two Phase 3 trials are recruiting patients to examine the efficacy and safety of the NS3/4A protease inhibitor simeprevir in combination with the nucleotide inhibitor sofosbuvir for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection in treatment-naive and treatment-experienced patients with and without cirrhosis.
A record number of elderly people are completing living wills to guide end-of-life medical treatments - up from 47 percent in 2000 to 72 percent in 2010 - according to new research from the University of Michigan and the Veterans Affairs Ann Arbor Healthcare System.
Nearly two years after the conclusion of its space shuttle program left Americans wondering what would become of the spacefaring dreams of decades past, NASA has sought the advice of health and ethics experts for protecting astronauts on its "next generation" of long duration and exploration-class human spaceflights.
The final days of open enrollment were marked by a surge that helped the Obama administration clear a key milepost. But not yet known is what this population actually looks like.
Patients, staff and visitors to the Ronald Reagan UCLA Medical Center and UCLA Medical Center, Santa Monica can now enjoy a healthier version of the traditional burger-and-fries lunch. The hospitals' menus now include burgers made from antibiotic-free, grass-fed beef and herb roasted potatoes, as well as antibiotic-free chicken breasts.
TomTom today launches the Runner Cardio GPS sport watch with cutting-edge heart rate technology. The Runner Cardio has a built-in Heart Rate Monitor, eliminating the need for a separate chest strap.
And in Hawaii and Los Angeles, some advocacy groups are worrying about providing health insurance to migrant workers and undocumented workers.
The battle for the future of Medicaid in Virginia is expected to heat up, with both sides of the divide playing close attention to a proposal to expand the program through the state budget.
Allegro Diagnostics Corp. today announced that the AEGIS-2 clinical trial has met its primary endpoint, demonstrating that the BronchoGen genomic test improves the accuracy of lung cancer diagnosis when used in combination with bronchoscopy.
Tetraphase Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration has granted Fast Track designations for both the intravenous (IV) and oral formulations of the company's lead antibiotic candidate, eravacycline.
In textbooks, the grand-finale of cell division is the tug-of-war fought inside dividing cells as duplicated pairs of chromosomes get dragged in opposite directions into daughter cells.